{"transactions":[{"id":743628,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39774,"kind":"person","name":"Walts Alan Edmund","position":1,"cik":"0001853544","reported_name":"Walts Alan Edmund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T00:00:57.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":8590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 24 substantially equal monthly installments so that the option will be fully vested and exercisable on the second anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date."}],"balance_after":8590,"derivative":{"exercise_price":11,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":8590},"source":{"system":"sec-edgar","filing":"0001193125-26-266278","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526266278/ownership.xml","form_type":"4"}},{"id":787289,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39774,"kind":"person","name":"Walts Alan Edmund","position":1,"cik":"0001853544","reported_name":"Walts Alan Edmund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:44:52.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":false,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested as to 50% on the first anniversary of January 24, 2024, and the remaining amount vested in two equal annual installments thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested as to 50% on the first anniversary of January 24, 2024, and the remaining amount vested in two equal annual installments thereafter."}],"balance_after":1875,"derivative":{"underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001193125-26-214815","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214815/ownership.xml","form_type":"4"}},{"id":787288,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39774,"kind":"person","name":"Walts Alan Edmund","position":1,"cik":"0001853544","reported_name":"Walts Alan Edmund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T20:44:52.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":395680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested as to 1/36 on October 31, 2025, with the remaining options vesting thereafter in equal consecutive monthly increments for 35 months, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date."}],"balance_after":395680,"derivative":{"exercise_price":0.15,"expiration_date":"2035-09-19","underlying":"Common Stock","underlying_shares":395680},"source":{"system":"sec-edgar","filing":"0001193125-26-214815","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214815/ownership.xml","form_type":"4"}},{"id":787287,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39774,"kind":"person","name":"Walts Alan Edmund","position":1,"cik":"0001853544","reported_name":"Walts Alan Edmund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-08T20:44:52.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":true,"shares":1875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":15567,"source":{"system":"sec-edgar","filing":"0001193125-26-214815","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526214815/ownership.xml","form_type":"4"}},{"id":1293344,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39774,"kind":"person","name":"Walts Alan Edmund","position":1,"cik":"0001853544","reported_name":"Walts Alan Edmund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-28T22:34:29.000Z","date":"2025-01-24","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."}],"balance_after":3750,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001104659-25-006781","document":"tm254730-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465925006781/tm254730-1_4seq1.xml","form_type":"4"}},{"id":1293343,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39774,"kind":"person","name":"Walts Alan Edmund","position":1,"cik":"0001853544","reported_name":"Walts Alan Edmund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-28T22:34:29.000Z","date":"2025-01-24","kind":"exercise","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16692,"source":{"system":"sec-edgar","filing":"0001104659-25-006781","document":"tm254730-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465925006781/tm254730-1_4seq1.xml","form_type":"4"}},{"id":1385141,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39774,"kind":"person","name":"Walts Alan Edmund","position":1,"cik":"0001853544","reported_name":"Walts Alan Edmund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-17T20:02:21.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This restricted stock grant was made pursuant to the Issuer's 2018 Equity Incentive Plan and vests as to 50% of the shares on October 16, 2025 and in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date."}],"balance_after":12942,"source":{"system":"sec-edgar","filing":"0001104659-24-109525","document":"tm2426349-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465924109525/tm2426349-5_4seq1.xml","form_type":"4"}},{"id":1669876,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39774,"kind":"person","name":"Walts Alan Edmund","position":1,"cik":"0001853544","reported_name":"Walts Alan Edmund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-01-26T21:33:26.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-24-007294","document":"tm244260-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465924007294/tm244260-4_4seq1.xml","form_type":"4"}},{"id":2040583,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39774,"kind":"person","name":"Walts Alan Edmund","position":1,"cik":"0001853544","reported_name":"Walts Alan Edmund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-01-31T21:12:17.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":2859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 50% of the underlying shares on the first anniversary of January 30, 2023, and the remaining 50% of the underlying shares will vest in twelve (12) equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date."}],"balance_after":2859,"derivative":{"exercise_price":4,"expiration_date":"2033-01-30","underlying":"Common Stock","underlying_shares":2859},"source":{"system":"sec-edgar","filing":"0001104659-23-008604","document":"tm234943-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465923008604/tm234943-4_4seq1.xml","form_type":"4"}},{"id":2228492,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39774,"kind":"person","name":"Walts Alan Edmund","position":1,"cik":"0001853544","reported_name":"Walts Alan Edmund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-06-17T12:29:27.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 50% of the underlying shares on June 15, 2023 and the remainder in twelve (12) equal monthly installments thereafter."}],"balance_after":20000,"derivative":{"exercise_price":0.26,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-072191","document":"tm2218714-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465922072191/tm2218714-8_4seq1.xml","form_type":"4"}},{"id":2486683,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39774,"kind":"person","name":"Walts Alan Edmund","position":1,"cik":"0001853544","reported_name":"Walts Alan Edmund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-12-03T22:16:42.000Z","date":"2021-12-01","kind":"exercise","acquired":false,"shares":37695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on April 1, 2021 have fully vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on April 1, 2021 have fully vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on April 1, 2021 have fully vested and settled for shares of the Issuer's common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":37695},"source":{"system":"sec-edgar","filing":"0001415889-21-005694","document":"form4-12032021_021230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921005694/form4-12032021_021230.xml","form_type":"4"}},{"id":2486682,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39774,"kind":"person","name":"Walts Alan Edmund","position":1,"cik":"0001853544","reported_name":"Walts Alan Edmund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-03T22:16:42.000Z","date":"2021-12-01","kind":"exercise","acquired":true,"shares":37695,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37695,"source":{"system":"sec-edgar","filing":"0001415889-21-005694","document":"form4-12032021_021230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921005694/form4-12032021_021230.xml","form_type":"4"}},{"id":2703645,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39774,"kind":"person","name":"Walts Alan Edmund","position":1,"cik":"0001853544","reported_name":"Walts Alan Edmund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T20:11:12.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was issued pursuant to the Issuer's 2018 Equity Incentive Plan and vests as follows: one half (1/2) of the shares underlying the option shall vest on May 19, 2022 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in twelve (12) equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":3334,"derivative":{"exercise_price":1.48,"expiration_date":"2031-05-19","underlying":"Common Stock","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001415889-21-002616","document":"form4-05202021_040547.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921002616/form4-05202021_040547.xml","form_type":"4"}},{"id":2762112,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39774,"kind":"person","name":"Walts Alan Edmund","position":1,"cik":"0001853544","reported_name":"Walts Alan Edmund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2021-04-03T01:04:21.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vests as follows: one-half of the shares underlying the option shall vest on April 1, 2022 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in twelve (12) equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":40000,"derivative":{"exercise_price":3.36,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-21-001851","document":"form4-04022021_060410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921001851/form4-04022021_060410.xml","form_type":"4"}},{"id":2762111,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":39774,"kind":"person","name":"Walts Alan Edmund","position":1,"cik":"0001853544","reported_name":"Walts Alan Edmund","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-04-03T01:04:21.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":37695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan. The restricted stock units will vest in full on December 1, 2021, subject to the Reporting Person's continued service with the Issuer, which vesting may be accelerated in connection with certain qualifying terminations of service or in connection with a corporate transaction. Promptly following vesting, and in any event on or prior to December 31, 2021, each restricted stock unit will be settled by delivery of one share of the Issuer's common stock to the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan. The restricted stock units will vest in full on December 1, 2021, subject to the Reporting Person's continued service with the Issuer, which vesting may be accelerated in connection with certain qualifying terminations of service or in connection with a corporate transaction. Promptly following vesting, and in any event on or prior to December 31, 2021, each restricted stock unit will be settled by delivery of one share of the Issuer's common stock to the Reporting Person."}],"balance_after":37695,"derivative":{"underlying":"Common Stock","underlying_shares":37695},"source":{"system":"sec-edgar","filing":"0001415889-21-001851","document":"form4-04022021_060410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921001851/form4-04022021_060410.xml","form_type":"4"}}]}